| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |